14-day Premium Trial Subscription Try For FreeTry Free

Range Low Price High Price Comment
30 days $22.23 $35.48 Thursday, 29th Feb 2024 AGIO stock ended at $32.32. This is 4.01% less than the trading day before Wednesday, 28th Feb 2024. During the day the stock fluctuated 6.25% from a day low at $32.24 to a day high of $34.25.
90 days $20.96 $35.48
52 weeks $19.80 $35.48

Historical Agios Pharmaceuticals prices

Date Open High Low Close Volume
2024-02-29 $34.25 $34.25 $32.24 $32.32 839 751
2024-02-28 $34.55 $35.48 $33.48 $33.67 868 117
2024-02-27 $33.00 $35.48 $32.90 $34.81 1 387 680
2024-02-26 $32.86 $33.69 $32.23 $32.87 941 513
2024-02-23 $29.87 $33.90 $29.87 $32.99 2 567 558
2024-02-22 $26.73 $30.05 $26.66 $29.78 1 504 353
2024-02-21 $27.11 $27.37 $26.50 $26.80 634 728
2024-02-20 $26.19 $27.13 $26.19 $27.10 905 399
2024-02-16 $26.41 $26.91 $26.02 $26.51 620 223
2024-02-15 $24.93 $27.00 $24.88 $26.80 1 081 432
2024-02-14 $25.44 $26.22 $25.20 $25.90 922 356
2024-02-13 $25.12 $25.42 $24.69 $25.15 1 207 611
2024-02-12 $25.27 $25.98 $24.75 $25.88 970 810
2024-02-09 $24.25 $25.17 $24.25 $25.14 688 130
2024-02-08 $23.76 $24.31 $23.70 $24.18 512 870
2024-02-07 $24.08 $24.08 $23.43 $23.69 400 778
2024-02-06 $23.89 $24.48 $23.71 $24.15 503 627
2024-02-05 $22.85 $23.81 $22.41 $23.73 525 916
2024-02-02 $22.60 $23.28 $22.50 $23.09 616 745
2024-02-01 $22.71 $23.00 $22.23 $22.96 472 069
2024-01-31 $22.79 $23.33 $22.51 $22.62 545 463
2024-01-30 $23.73 $23.86 $22.66 $22.86 606 956
2024-01-29 $23.27 $24.08 $22.72 $23.87 586 986
2024-01-26 $23.48 $23.66 $22.92 $23.38 626 941
2024-01-25 $21.77 $23.45 $21.66 $23.42 1 105 034
Click to get the best stock tips daily for free!

About Agios Pharmaceuticals

Agios Pharmaceuticals Agios Pharmaceuticals, Inc., a biopharmaceutical company, engages in the discovery and development of medicines in the field of cellular metabolism and adjacent areas of biology. The company offers PYRUKYND (mitapivat) an activator of both wild-type and a variety of mutant pyruvate kinase, PK, enzymes for the treatment of hemolytic anemias; and AG-946 that is in Phase I clinical study for treating hemolytic anemias and other indications. Agios Ph... AGIO Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT